Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2004
03/24/2004CN1142916C Dopamine D1 receptor agonist compounds
03/24/2004CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure
03/23/2004US6710209 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
03/23/2004US6710191 9β-hydroxytetracyclic taxanes
03/23/2004US6710078 Antitumor, anticancer agents
03/23/2004US6710069 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/23/2004US6710060 4-hydroxypiperidine derivatives having antiarrhythmic activity
03/23/2004US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders
03/23/2004US6710057 Inhibitors of factor xa, as anticoagulants for prophylaxis and treatment of thromboembolic disorders
03/23/2004US6710055 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbo quinoline-8-sulfonylamino)-indole
03/23/2004US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
03/18/2004WO2004022712A2 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
03/18/2004WO2004022551A1 Furan or thiophene derivative and medicinal use thereof
03/18/2004WO2004022544A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
03/18/2004WO2004022542A2 Substituted 1,2,3,4-tetrahydroquinoline derivatives
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors
03/18/2004WO2004009583A3 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
03/18/2004WO2004009543A3 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors
03/18/2004WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor
03/18/2004WO2004006355A3 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions
03/18/2004WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction
03/18/2004WO2003097608A3 Opioid and opioid-like compounds and uses thereof
03/18/2004WO2003087094A3 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
03/18/2004WO2003070731A3 Azabicyclic compounds for the treatment of disease
03/18/2004US20040054196 Method for producing cyclic carboxylic orthoester fluorides and corresponding compounds
03/18/2004US20040054187 Therapeutic ureas
03/18/2004US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders
03/18/2004US20040054180 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents
03/18/2004US20040053970 Emzyme inhibitors, a 4-pyridinyl-3-pyrazoles derivatives, treating animal having cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic; a plant having yeast infection and viral infection
03/18/2004US20040053964 N-type calcium channel antagonists for the treatment of pain
03/18/2004US20040053953 Treatment of chemokine mediated diseases
03/18/2004US20040053943 Novel compounds
03/18/2004US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto
03/18/2004US20040053926 Triazine compounds
03/18/2004US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
03/18/2004CA2501924A1 Non-nucleoside reverse transcriptase inhibitors
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004CA2497901A1 Furan or thiophene derivative and medicinal use thereof
03/18/2004CA2497408A1 Indole-type derivatives as inhibitors of p38 kinase
03/17/2004EP1398029A1 NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives
03/17/2004EP1398028A2 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
03/17/2004EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy
03/17/2004EP1397350A1 Isoquinolinone derivatives as parp inhibitors
03/17/2004EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
03/17/2004EP1242406B1 Novel compounds
03/17/2004EP1224175B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
03/17/2004EP1147102B1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
03/17/2004EP1140839B1 Heterocyclic amides as inhibitors of factor xa
03/17/2004EP1008594B1 Compounds derived from thophene and benzothiophene, and related utilisation and composition
03/17/2004EP0891332B1 6-phenylpyridyl-2-amine derivatives
03/17/2004CN1483031A Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
03/17/2004CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders
03/17/2004CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors
03/17/2004CN1482912A Heteroaryl urea neuropeptide yy5 receptor antagonists
03/16/2004US6706891 Comprises conversion of oxalamide to dithiooxalamide, followed by conversion of the dithiooxalamide to either a 4,5-bisimino-(1,3)dithiolane or 2,3-bisimino-(1,4)dithiane
03/16/2004US6706757 Chroman derivatives as 5-hydroxytryptamine-6 ligands
03/16/2004US6706754 Antiprotozoa agents, parasiticides
03/16/2004US6706751 Dihydroindole and tetrahydroquinoline derivatives
03/16/2004US6706743 β3 adrenergic receptor agonists and uses thereof
03/16/2004US6706740 Controlling, prevention fungi infections
03/16/2004US6706703 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (ige) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases
03/16/2004US6706338 Liquid-crystalline compounds
03/16/2004US6706021 Anticoagulant for catheters, dialysis machines, syringes, tubes, blood lines and stents; trypsin-like serine proteases such as thrombin; 3-benzylsulfonylamino-6-methyl-1-((2-guanidinooxyethyl) aminocarbonylmethyl)-2-pyridinone
03/11/2004WO2004020434A1 Azaarene derivatives
03/11/2004WO2004020432A1 Arylamides
03/11/2004WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
03/11/2004WO2004020402A1 Sulphonylamino derivatives for the treatment of alzheimer's disease
03/11/2004WO2004019943A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/11/2004WO2004019935A1 -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
03/11/2004WO2004009578A3 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them
03/11/2004WO2003074091A3 Near infrared fluorescent contrast agent and method for fluorescence imaging
03/11/2004WO2003009845A9 Substituted urea neuropeptide y y5 receptor antagonists
03/11/2004US20040049046 Small molecule inhibitors of rotamase enzyme activity
03/11/2004US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
03/11/2004US20040049035 Pyrrolecarboxamides and pyrrolethioamides as fungicides
03/11/2004US20040048895 Caspase-1 inhibitors and methods for their use
03/11/2004US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc.
03/11/2004US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted
03/11/2004US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics.
03/11/2004US20040048868 Benzimidazoles
03/11/2004US20040048867 Especially quinoline carbonyl pyrrolidines with binding selectivity to benzodiazepine site of GABAA receptor to treatanxiety, depression, a sleep disorder, or cognitive impairment.
03/11/2004US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/11/2004US20040048863 Treating osteoarthritis or rheumatoid arthritis
03/11/2004US20040048858 Chalcone derivatives and their use to treat diseases
03/11/2004US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
03/11/2004US20040048848 Novel gamma secretase inhibitors
03/11/2004US20040048844 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
03/11/2004US20040048843 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion
03/11/2004US20040048797 Regulation of TNF-alpha
03/11/2004US20040046150 Liquid-crystalline media comprising at least compound of the formula I and to electro-optical displays containing a liquid-crystalline medium of this type.
03/11/2004DE10236910A1 Substituierte 1,2,3,4-Tetrahydrochinolinderivate Substituted 1,2,3,4-tetrahydroquinoline
03/11/2004CA2496580A1 3-(sulfonamidoethyl)-indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
03/11/2004CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
03/11/2004CA2495248A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/11/2004CA2488739A1 Nitrogen-containing aromatic derivatives
03/10/2004EP1396490A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
03/10/2004EP1396487A1 Phenylpyridine carbonyl piperazine derivative
03/10/2004EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
03/10/2004EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins